Additionally, genetic studies have reported that TP53 is the most frequently mutated gene in oral cancer and that TP53 mutation is a prognostic biomarker for poor outcomes in head and neck cancer [36]. This evidence concerns the gene TP53 and lip and oral cavity carcinoma.